Mycophenolate Mofetil Is Ineffective in the Treatment of Mucocutaneous Adamantiades-Behçet’s Disease

Publisher： Karger

E-ISSN： 1421-9832|203|4|322-324

ISSN： 1018-8665

Source： Dermatology, Vol.203, Iss.4, 2001-12, pp. : 322-324

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oxidative Stress in Adamantiades-Behçet’s Disease

By  

Dermatology, Vol. 197, Iss. 4, 1998-12 ,pp. : 343-348

Karger

Access to resources Recommend Favorite

Adamantiades-Behçet’s Disease: Serum IL-8 Is a More Reliable Marker for Disease Activity than C-Reactive Protein and Erythrocyte Sedimentation Rate

By  

Dermatology, Vol. 201, Iss. 1, 2000-08 ,pp. : 37-39

Karger

Access to resources Recommend Favorite

Juvenile Adamantiades-Behçet Disease

By  

Dermatology, Vol. 232, Iss. 2, 2016-01 ,pp. : 129-136

Karger

Access to resources Recommend Favorite

Infliximab for the Treatment of Refractory Adamantiades-Behçet Disease with Articular, Intestinal, Cerebral and Ocular Involvement

By  

Dermatology, Vol. 220, Iss. 3, 2010-01 ,pp. : 282-286

Karger

Access to resources Recommend Favorite

Twenty-Eight Cases of Juvenile-Onset Adamantiades-Behçet Disease in Germany

By  

Dermatology, Vol. 199, Iss. 1, 1999-08 ,pp. : 15-19

Karger

Access to resources Recommend Favorite